Robinson Elliott sold 0 shares of HNGE (indirect holdings)
Robinson Elliott sold 0 indirectly-held shares of Hinge Health, Inc. (HNGE) on 2026-06-02.
How this was made
The 30-second read
Why it matters
Because the reported transaction is an open-market sale of 0 shares and holdings after transaction are 0, the disclosure does not introduce new economic exposure or capital-market information.
Market read
Insider-trading headlines are unlikely to move HNGE given the 0-share sale and no disclosed value.
What to watch
Check for related filings (other directors/officers, option exercises, or amended Form 4s) that may contain the real change in beneficial ownership.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for Hinge Health, Inc. (HNGE) by director Robinson Elliott.
Ticker impact
SEC Form 4 shows director Robinson Elliott filed an open-market sale with 0 shares, implying no actual disposition occurred.
Minimal to none; any reaction is likely noise unless other filings/changes accompany it.
Form 4 reports 0 shares sold and holdings after transaction of 0 shares, with no disclosed price/value and no 10b5-1 plan.
Market effects
No meaningful read-through to the digital health/healthcare SaaS sector from a 0-share insider transaction.
None indicated.
None indicated.
Counterpoint
A 0-share Form 4 can still reflect administrative updates or option/plan mechanics, but the filing provides no actionable economic change here.
Key entities
- issuerHinge Health, Inc.
Subject of the Form 4 insider transaction disclosure (HNGE).
- insiderRobinson Elliott
Director who filed the Form 4; reported sale of 0 shares.
